Aktie A3CWYJ SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shanghai HeartCare Medical Technology Corporation Limited

Aktien

A3CWYJ

CNE100004MN5

6609

Verzögert Hong Kong S.E.
Andere Börsenplätze
 08:59:40 27.06.2024 		% 5 Tage % 1. Jan.
16,06 HKD -1,59 % Intraday Chart für Shanghai HeartCare Medical Technology Corporation Limited -0,74 % -46,02 %
28.03. Shanghai HeartCare Medical Technology Corporation Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Shanghai Heartcare Medical Technology Corporation Limited ernennt Xue Zongyu zum Vorsitzenden des Aufsichtsausschusses CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index
HeartCare Medical Technology's Loss Narrows in H1
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Ouyang Xiangyu as Non-Executive Director
Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director
Shanghai HeartCare Medical Technology Corporation Limited Voluntary Receives Approval from the National Medical Products Administration for registration application for LAA Occluder
Shanghai Heartcare Medical Technology Corporation Limited Receives the Approvals from the National Medical Products Administration of the PRC for the Registration Applications for the Aspiration Catheter and Support Catheter
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CWYJ Aktie
  4. Nachrichten Shanghai HeartCare Medical Technology Corporation Limited
  5. Andere Sprachen